ResultsMoneycontrol
Beta Drugs Consolidated September 2026 Net Sales at Rs 137.49 crore, up 32.99% Y-o-Y
Positive+20
GreyOak summary
Beta Drugs reported consolidated net sales of Rs 137.49 crore for September 2026, a 32.99% increase from the previous year. Quarterly net profit reached Rs 18.55 crore, up 51.83% year-on-year, while EBITDA stood at Rs 32.03 crore. The company's EPS increased to Rs 16.59.
What it affects
- Beta DrugsBETAPositive +20
Net sales and profit rose significantly year-on-year.Rolling sentiment Positive +47
Source
Read the original at MoneycontrolMore Beta Drugs news
- Beta Drugs Standalone September 2026 Net Sales at Rs 58.01 crore, up 6.48% Y-o-YMoneycontrol · Results ·